BIOAGE LABS

company

About

BIOAGE targets aging to develop drugs that treat severe diseases

  • 1 - 10

Details

Last Funding Type
Series C
Last Funding Money Raised
$90M
Industries
Biotechnology,Computer
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

BIOAGE discovers and develops drugs to treat aging and associated diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$113M
BIOAGE LABS has raised a total of $113M in funding over 2 rounds. Their latest funding was raised on Dec 3, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 3, 2020 Series C $90M 1 Detail
Jan 24, 2019 Series B $23M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
BIOAGE LABS is funded by 1 investors. Redpoint are the most recent investors.
Investor Name Lead Investor Funding Round
Redpoint Series C